Evaluation of Renal Safety Between Imipenem/Relebactam and Colistin Plus Imipenem in Patients With Imipenem-Nonsusceptible Bacterial Infections in the Randomized, Phase 3 RESTORE-IMI 1 Study.
Saved in:
| Title: | Evaluation of Renal Safety Between Imipenem/Relebactam and Colistin Plus Imipenem in Patients With Imipenem-Nonsusceptible Bacterial Infections in the Randomized, Phase 3 RESTORE-IMI 1 Study. |
|---|---|
| Authors: | Brown, Michelle L1 (AUTHOR), Motsch, Johann2 (AUTHOR), Kaye, Keith S3 (AUTHOR), File, Thomas M4 (AUTHOR), Boucher, Helen W5 (AUTHOR), Vendetti, Neika1 (AUTHOR), Aggrey, Angela1 (AUTHOR), Joeng, Hee-Koung1 (AUTHOR), Tipping, Robert W1 (AUTHOR), Du, Jiejun1 (AUTHOR), DePestel, Daryl D1 (AUTHOR), Butterton, Joan R1 (AUTHOR), Paschke, Amanda1 (AUTHOR) amanda.paschke@merck.com |
| Source: | Open Forum Infectious Diseases. Mar2020, Vol. 7 Issue 3, pN.PAG-N.PAG. 1p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
